The Role and Significance of Non-invasive Methods, with a Particular Focus on Shear Wave Elastography in Hepatic Fibrosis Staging

Arzana Hasani Jusufi; Meri Trajkovska; Rozalinda Popova-Jovanovska; Viktorija Calovska-Ivanova; Atip Ramadani; Vladimir Andreevski

doi:10.3889/oamjms.2022.9048

Authors

Arzana Hasani Jusufi Clinic of Gastroenterohepatology https://orcid.org/0000-0002-4388-7145
Meri Trajkovska Clinic of Gastroenterohepatology, Ss. Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia
Rozalinda Popova-Jovanovska Clinic of Gastroenterohepatology
Viktorija Calovska-Ivanova Clinic of Gastroenterohepatology, Ss. Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia
Atip Ramadani Clinic of Gastroenterohepatology, Ss. Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia
Vladimir Andreevski Clinic of Gastroenterohepatology, Ss. Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia

DOI:

https://doi.org/10.3889/oamjms.2022.9048

Keywords:

Liver/hepatic fibrosis, Diffuse liver disease, Shear wave elastography, Serum markers of liver fibrosis

Abstract

Shear Wave Elastography (SWE) represents a new, non-invasive method, used in the diagnosis of diffuse liver diseases. The method has been widely used instead of liver biopsy - an invasive procedure with potential major risk complications. Compared to liver biopsy, SWE provides an examination of larger areas of the liver, thus providing better staging of hepatic fibrosis.

30 patients were included in the study on basis of previous clinical, biochemical, and ultrasound findings indicating a presence of a chronic liver lesion. Patients were divided into three groups: 6 patients with steatosis, 13 patients with viral hepatitis, and 11 patients with liver cirrhosis. Liver damage biochemical markers, serum markers of liver fibrosis, and SWE were determined in all patients. Statistical analysis revealed a positive correlation between SWE results, and the values of biochemical markers of the hepatic lesion, as well as serum markers of liver fibrosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis: Definition, nomenclature, and classification. Bull World Health Organ. 1977;55(4):521-40. PMid:304393

Con HO. Cirrhosis. In: Schiff L, editor. Diseases of the Liver. 4th ed. Philadelphia: J.B Lippincott Company; 1957. p. 833.

Popper H, Uenfriend S. Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am J Med. 1970;49:707-21. https://doi.org/10.1016/s0002-9343(70)80135-8 PMid:4924592 DOI: https://doi.org/10.1016/S0002-9343(70)80135-8

Schaffner F, Klion FM. Chronic hepatitis. Ann Rev Med. 1968;19:25-38. https://doi.org/10.1146/annurev.me.19.020168.000325 DOI: https://doi.org/10.1146/annurev.me.19.020168.000325

Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis. 2001;5(2):315-34, v-vi. https://doi.org/10.1016/s1089-3261(05)70168-9 PMid:11385966 DOI: https://doi.org/10.1016/S1089-3261(05)70168-9

Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: Morphological and functional characteristics in primary culture. Hepatology. 1992;15(2):234-43. https://doi. org/10.1002/hep.1840150211 PMid:1735526 DOI: https://doi.org/10.1002/hep.1840150211

Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001;21(3):311-35. https://doi.org/10.1055/s-2001-17550 PMid:11586463 DOI: https://doi.org/10.1055/s-2001-17550

Otto DA, Veech RL. Isolation of a lipocyte-rich fraction from rat liver nonparenchymal cells. Adv Exp Med Biol. 1980;132:509- 17. https://doi.org/10.1007/978-1-4757-1419-7_52 PMid:6999873 DOI: https://doi.org/10.1007/978-1-4757-1419-7_52

Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol. 1992;24(2):193-203. PMid:1600511

Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 1989;84(6):1786-93. https://doi.org/10.1172/JCI114363 PMid:2592560 DOI: https://doi.org/10.1172/JCI114363

Wasser S, Tan CE. Experimental models of hepatic fibrosis in the rat. Ann Acad Med Singap. 1999;28(1):109-11. PMid:10374036

Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest. 2004;84(2):153-9. https://doi.org/10.1038/labinvest.3700030 PMid:14688800 DOI: https://doi.org/10.1038/labinvest.3700030

Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology. 2004;126(4):955-63. https://doi.org/10.1053/j.gastro.2004.02.025 PMid:15057733 DOI: https://doi.org/10.1053/j.gastro.2004.02.025

Poynard T, Ratziu V, Benhamou Y, Opolon P, Cacoub P, Bedossa P. Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(2):211-28. https://doi.org/10.1053/bega.1999.0071 DOI: https://doi.org/10.1053/bega.1999.0071

Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349(9055):825-32. https://doi.org/10.1016/s0140-6736(96)07642-8 PMid:9121257 DOI: https://doi.org/10.1016/S0140-6736(96)07642-8

Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology. 2003;37(3):493-503. https://doi.org/10.1053/jhep.2003.50127 PMid:12601343 DOI: https://doi.org/10.1053/jhep.2003.50127

Hammel P, Couvelard A, O’Toole D, Ratouis A, Sauvanet A, Fléjou JF, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med. 2001;344(6):418-23. https://doi.org/10.1056/NEJM200102083440604 PMid:11172178 DOI: https://doi.org/10.1056/NEJM200102083440604

Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (short version). Ultraschall Med. 2017;38(4):377-94. https://doi.org/10.1055/s-0043-103955 PMid:28407654 DOI: https://doi.org/10.1055/s-0043-103955

Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51(10):1867-73. https://doi.org/10.1373/clinchem.2005.048389 PMid:16055434 DOI: https://doi.org/10.1373/clinchem.2005.048389

Niemelä O, Blake JE, Orrego H. Serum type I collagen propeptide and severity of alcoholic liver disease. Alcohol Clin Exp Res. 1992;16(6):1064-7. https://doi.org/10.1111/j.1530-0277.1992.tb00700.x PMid:1471760 DOI: https://doi.org/10.1111/j.1530-0277.1992.tb00700.x

Montalto G, Soresi M, Aragona F, Tripi S, Carroccio A, Anastasi G, et al. Procollagen III and laminin in chronic viral hepatopathies. Presse Med 1996;25(2):59-62. PMid:8745719

Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: Collagen type IV, laminin, and fibronectin. Gut. 1980;21(1):63-71. https://doi.org/10.1136/gut.21.1.63 PMid:6988303 DOI: https://doi.org/10.1136/gut.21.1.63

McGary CT, Raja RH, Weigel PH. Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling. Biochem J. 1989;257(3):875-84. https://doi.org/10.1042/bj2570875 PMid:2930491 DOI: https://doi.org/10.1042/bj2570875

Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 1996;110(3):821-31. https://doi.org/10.1053/gast.1996.v110.pm8608892 PMid:8608892 DOI: https://doi.org/10.1053/gast.1996.v110.pm8608892

Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJ. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci. 1995;89(1):75-81. https://doi.org/10.1042/cs0890075 PMid:7671571 DOI: https://doi.org/10.1042/cs0890075

Baranova A, Lal P, Birerdinc A, Younossi ZM. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 2011;11:91. https://doi.org/10.1186/1471-230X-11-91 PMid:21849046 DOI: https://doi.org/10.1186/1471-230X-11-91

Eisenberg E, Konopniki M, Veitsman E, Kramskay R, Gaitini D, Baruch Y. Prevalence and characteristics of pain induced by percutaneous liver biopsy. Anesth Analg. 2003;96(5):1392-6. https://doi.org/10.1213/01.ANE.0000060453.74744.17 PMid:12707140 DOI: https://doi.org/10.1213/01.ANE.0000060453.74744.17

Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology (Baltimore, Md). 2009;49(3):1017-44. https://doi.org/10.1002/hep.22742 DOI: https://doi.org/10.1002/hep.22742

Siegel CA, Silas AM, Suriawinata AA, van Leeuwen DJ. Liver biopsy 2005: When and how? Cleve Clin J Med. 2005;72(3):199- 201, 206, 208 passim. https://doi.org/10.3949/ccjm.72.3.199 PMid:15825800 DOI: https://doi.org/10.3949/ccjm.72.3.199

Friedman LS. Controversies in liver biopsy: Who, where, when, how, why? Curr Gastroenterol Rep. 2004;6(1):30-6. https://doi.org/10.1007/s11894-004-0023-4 PMid:14720451 DOI: https://doi.org/10.1007/s11894-004-0023-4